• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Introduction to Tert-Butyl 2,6-Dichloroisonicotinate (CAS No. 75308-46-2)

Tert-Butyl 2,6-Dichloroisonicotinate, identified by the Chemical Abstracts Service Number (CAS No.) 75308-46-2, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound, characterized by its tert-butyl ester group and the presence of two chlorine atoms at the 2 and 6 positions of the isonicotinic acid moiety, exhibits unique chemical properties that make it a valuable intermediate in synthetic chemistry. The structural features of Tert-Butyl 2,6-Dichloroisonicotinate contribute to its reactivity and utility in various synthetic pathways, particularly in the development of novel bioactive molecules.

The tert-butyl group, a bulky alkyl substituent, plays a crucial role in modulating the electronic and steric properties of the molecule. This group can enhance the lipophilicity of the compound, making it more suitable for membrane interactions or improving its solubility in organic solvents. Additionally, the presence of chlorine atoms at the 2 and 6 positions introduces electrophilic centers that can participate in nucleophilic substitution reactions, facilitating further functionalization. These characteristics make Tert-Butyl 2,6-Dichloroisonicotinate a versatile building block for constructing more complex molecules.

In recent years, there has been growing interest in exploring the pharmacological potential of derivatives of isonicotinic acid. Isonicotinic acid and its derivatives have been extensively studied for their antimicrobial and anti-inflammatory properties. The substitution pattern in Tert-Butyl 2,6-Dichloroisonicotinate may influence its biological activity by affecting binding affinity to target enzymes or receptors. For instance, studies have shown that halogenated isonicotinic acid derivatives can exhibit enhanced potency against certain bacterial enzymes due to increased electrophilicity. This has led to investigations into their use as potential antibiotics or antiviral agents.

One of the most compelling aspects of Tert-Butyl 2,6-Dichloroisonicotinate is its role as a precursor in the synthesis of more complex pharmacophores. Researchers have utilized this compound to develop novel inhibitors targeting various therapeutic pathways. For example, derivatives of isonicotinic acid have been explored as inhibitors of enzymes involved in cancer metabolism. The tert-butyl group and chlorinated aromatic ring provide a scaffold that can be modified to optimize binding interactions with biological targets. This flexibility has made Tert-Butyl 2,6-Dichloroisonicotinate a valuable asset in drug discovery pipelines.

The synthesis of Tert-Butyl 2,6-Dichloroisonicotinate typically involves the esterification of 2,6-dichloroisonicotinic acid with tert-butanol under acidic conditions. This reaction can be catalyzed by various acids, such as sulfuric acid or hydrochloric acid, and often requires careful control of temperature and stoichiometry to ensure high yield and purity. The resulting product can then be purified using techniques such as recrystallization or column chromatography to obtain the desired compound in high purity.

In industrial applications, Tert-Butyl 2,6-Dichloroisonicotinate is often used as an intermediate in large-scale synthesis processes. Its stability under various reaction conditions makes it suitable for use in multi-step synthetic routes where harsh reagents or elevated temperatures are required. Additionally, its compatibility with a wide range of solvents allows for flexibility in reaction setup and purification strategies.

Recent advancements in computational chemistry have also contributed to the understanding of Tert-Butyl 2,6-Dichloroisonicotinate's reactivity and potential applications. Molecular modeling studies have helped predict how modifications to its structure might affect its biological activity. These predictions are often validated through experimental synthesis and biological testing, leading to iterative improvements in molecular design.

The agrochemical sector has also shown interest in Tert-Butyl 2,6-Dichloroisonicotinate due to its potential as a precursor for herbicides or pesticides. The structural features that make this compound useful in pharmaceutical applications can also contribute to its efficacy as an agrochemical agent. By leveraging computational tools and synthetic chemistry techniques, researchers aim to develop derivatives that offer improved environmental profiles while maintaining high efficacy against target pests or weeds.

In conclusion,Tert-Butyl 2,6-Dichloroisonicotinate (CAS No. 75308-46-2) is a multifaceted compound with significant potential in both pharmaceutical and agrochemical research. Its unique structural features enable diverse applications in synthetic chemistry and drug discovery. As research continues to uncover new therapeutic targets and synthetic methodologies,Tert-Butyl 2,6-Dichloroisonicotinate is likely to remain a key intermediate in the development of novel bioactive molecules.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)